You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page

Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches
ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Recommended for you

A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU
Dermatology
expert video

A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU

Recently added

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in Prurigo Nodularis and Chronic Spontaneous Urticaria
Dermatology
expert video

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in Prurigo Nodularis and Chronic Spontaneous Urticaria

Connecting the Dots: Novel Insights on Type 2 Cytokines Mediating Neuroimmune Dysregulation in PN and CSU
Dermatology
expert video

Connecting the Dots: Novel Insights on Type 2 Cytokines Mediating Neuroimmune Dysregulation in PN and CSU

Itch and Inflammation in Two Distinct Diseases: PN and CSU
Dermatology
expert video

Itch and Inflammation in Two Distinct Diseases: PN and CSU

The Cumulative Disease Burden of AD in Adult Patients
Dermatology
expert video

The Cumulative Disease Burden of AD in Adult Patients

Practical Considerations in Older Patients with AD
Dermatology
expert video

Practical Considerations in Older Patients with AD

Long-term Impacts of AD and the Potential Benefit of Early Intervention
Dermatology
expert video

Long-term Impacts of AD and the Potential Benefit of Early Intervention

New Data on the Systemic (Multi-Organ) Burden of AD in Children and the Need for Early Intervention
Dermatology
expert video

New Data on the Systemic (Multi-Organ) Burden of AD in Children and the Need for Early Intervention

Is Pediatric AD Linked to Other Allergic Diseases?
Dermatology
expert video

Is Pediatric AD Linked to Other Allergic Diseases?

Inflamm-aging: Systemic Inflammation and Frailty in Older Adults
Dermatology
expert video

Inflamm-aging: Systemic Inflammation and Frailty in Older Adults

Characteristics of Chronic Itch in PN and CSU
Dermatology
expert video

Characteristics of Chronic Itch in PN and CSU

Scratching May Increase Neurogenic Inflammation in PN and CSU
Dermatology
expert video

Scratching May Increase Neurogenic Inflammation in PN and CSU

Type 2 Inflammation at the Neuroimmune Axis in PN and CSU
Dermatology
expert video

Type 2 Inflammation at the Neuroimmune Axis in PN and CSU

ADVENT On Air | Remission in CRSwNP
Rhinology
audio

ADVENT On Air | Remission in CRSwNP

The Benefits of Early Intervention in AD: More Than Skin Deep
Dermatology
slide presentation

The Benefits of Early Intervention in AD: More Than Skin Deep

The Burden of Chronic Spontaneous Urticaria
Dermatology
videoanimation

The Burden of Chronic Spontaneous Urticaria

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis
Dermatology
videoanimation

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients
Pulmonology
Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

Skin Dyspigmentation In Prurigo Nodularis (PN)
Dermatology
interactivity

Skin Dyspigmentation In Prurigo Nodularis (PN)

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features
Pulmonology
expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
Pulmonology
expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Popular in United States

What Do We Know About Type 2 Inflammation in COPD?
Pulmonology
expert video

What Do We Know About Type 2 Inflammation in COPD?

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?
Pulmonology
expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD
Pulmonology
expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand events highlights

6 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

View more
8 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

The following materials review the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient, improving clinical management and reducing long-term patient burden.

View more
2 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

View more
3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of biomarker assessments in guiding management strategies of recognizing the heterogeneity of COPD.

View more
6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

View more
3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

Join Drs. James Del Rosso and Raj Chovatiya for an education program to explore the impact, contribution, and diagnosis of type 2 inflammation on atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

View more
3 assets

ERS 2023 | COPD Symposium | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

View more
11 assets

AAD Meeting 2023: Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

View more
Explore all educational resources

Upcoming events

20May2024
Symposium

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join experts Mario Castro, Nicola Hanania, and Stephanie Christenson for an educational symposium on the real-world impact of underlying type 2 inflammation on the patient burden of asthma and COPD.

Future events

20May2024
Symposium

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Hear from ADVENT experts

“Many gastroenterologists have little experience with type 2 inflammatory diseases, and the ADVENT medical education program can help them gain more insights into this phenomenon.”
Gastroenterologist
Prof. Arjan Bredenoord
“I think there’s a lot of key things that will be coming from the ADVENT program. I think the first thing is understanding of mechanisms of disease and the uniformity of the T2 pathway. Bringing us together leads to better appreciation of the different diseases and a better understanding of how they are co-related and how they can be more effectively treated.”
Allergist-Immunologist
Dr. William Busse
“I think it’s really important to have these sorts of educational sessions to hear what thought leaders think about the regulatory studies and their outcomes.”
Dermatologist
Dr. Lisa Beck
“The ADVENT program allows the understanding of the science behind the [esophageal] inflammation, and that the inflammation is a type 2 inflammation.”
Gastroenterologist
Dr. Kathryn Peterson
“It’s very important that you have a medical education program such as ADVENT to help allergists understand, in an easy and accessible way, the type 2 inflammation driving mechanisms in a disease such as EoE.”
Allergist
Prof. Ingrid Terreehorst
“This program is all you ever wanted to know about atopic dermatitis and comorbidities, but you never asked for.”
Dermatologist
Prof. Thomas Bieber
“What we have here is a well put together program by experts in the whole field of asthma and T2 diseases.”
Primary Care Respiratory Medicine
Prof. David Price
“What I appreciate about the ADVENT program is that it bringing together physicians from a number of different countries. It’s been very interesting to see the regional differences in not only the practice patterns but also the types of asthma, types of patients that they see.”
Pulmonologist
Dr. Monica Kraft
“ADVENT is a really important platform to raise the bar of education in relation to AD. By raising awareness of comorbidities, as a very important example, we can help improve the whole global management of AD.”
Dermatologist
Prof. Michael Cork
“This extends beyond simply having lung doctors and allergists working together to having lung physicians, allergologists collaborating with ENTs.”
Otolaryngologist
Prof. Martin Desrosiers
“It regularly brings together people from across the world, specialists from across the world, updates them on the newest insights from clinical and molecular research, and gives them an opportunity to exchange their experiences. And I think this is quite important to improve patient care.”
Dermatologist
Prof. Stephan Weidinger

Meet our experts

Dermatology
MD, MA

Katrina Abuabara

Allergy/Immunology
MD, PhD

Seema Aceves

Pulmonology
MD, PhD

Alvar Agusti

Dermatology
MD, PhD

Paolo Amerio

Allergy/Immunology
MD, PhD

Peter Arkwright

Gastroenterology
MD, PhD

Ulrike von Arnim

Gastroenterology
MD, FRCPC

Dhandapani Ashok

Allergy/Immunology
MD

Leonard Bacharier

Rhinology
MD, PhD

Claus Bachert

Pulmonology
DMSc, MD

Vibeke Backer

Pulmonology
MD, PhD

Igor Barjaktarevic

Dermatology
MD, PhD

Eulàlia Baselga

Pulmonology
FERS, FRCS, MBChB, MD

Eric Bateman

Dermatology
MD

Lisa Beck

Dermatology
MD

Anna Belloni Fortina

Allergy/Immunology
MD

Tilo Biedermann

Dermatology
MD

Robert Bissonnette

Allergy/Immunology
FAAAAI, FACAAI, MD

Michael Blaiss

Pulmonology
MD

Eugene R. Bleecker

Allergy/Immunology
MD

Mark Boguniewicz

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region